Canada's first homegrown COVID-19 vaccine has shown high efficacy against infection during Phase 3 clinical trials, the drugmakers behind the plant-based shot reported Tuesday, fuelling hopes it could soon get a stamp of approval for use. The results followed a global, Phase 3, placebo-controlled study of the two-dose vaccine that was launched last March. In the vaccine's Phase 3 trial, no severe cases of COVID-19 were reported in the vaccinated group, the release notes. Canada’s first homegrown COVID-19 vaccine has shown high efficacy against infection during Phase 3 clinical trials, the drugmakers behind the plant-based shot reported Tuesday. WATCH | Canada's first homegrown COVID-19 vaccine shows promising early results: The importance of Canada’s 1st home-grown COVID-19 vaccine Duration 4:52 Quebec company Medicago is getting ready to submit data about its COVID-19 vaccine for final regulatory approval, which is a significant step for the pandemic and Canada's bio-pharmaceutical industry.

Source: CBC News December 08, 2021 05:42 UTC